Exchange & Returns Information
Review Details
(0)
| Generic For | CONTRAVE|MYSIMBA |
|---|---|
| Active Ingredient | NALTREXONE|BUPROPION |
| Strength | 8MG|90MG |
| Manufacturer | KACHHELA MEDEX |
| Pack Size | Price Per Unit | Unit Price | QTY | CART | Best Coupon Price MAX DISCOUNT |
|---|---|---|---|---|---|
| 1 BOX - 60 TABLETS | $ 1.05 | $ 62.90 |
$ 53.46
Apply ZARVY26 (-15%)
You save $ 9.44
|
||
| 2 BOXES - 120 TABLETS | $ 0.95 |
9% $ 125.80
$ 114.00
|
$ 96.90
Apply ZARVY26 (-15%)
You save $ 17.10
|
||
| ★ Best Value 3 BOXES - 180 TABLETS | $ 0.86 |
18% $ 188.70
$ 154.80
|
$ 131.58
Apply ZARVY26 (-15%)
You save $ 23.22
|
Reference information will be available soon.
Lodonak BP is a fixed-dose combination of Naltrexone 8mg and Bupropion 90mg formulated for chronic weight management. It targets multiple neurological pathways to reduce appetite, emotional eating, and cravings, while also supporting mental health. Acting on the brain’s reward system, it enhances satiety and decreases compulsive behavior, making it a powerful option for individuals struggling with obesity and mood regulation. As a generic counterpart to the FDA-approved Contrave, Lodonak BP delivers comparable efficacy with improved accessibility for long-term treatment goals.
- Sleep & Mental Health > Depression (Bupropion component) Bupropion enhances dopamine and norepinephrine activity in the brain, offering antidepressant effects without the weight gain seen with many other antidepressants, making it particularly suitable for overweight patients. - Smoking Cessation Treatment > Nicotine Withdrawal Bupropion reduces nicotine cravings and eases withdrawal symptoms, helping smokers manage anxiety, irritability, and poor concentration during cessation. It is widely used in smoking cessation protocols. - Sleep & Mental Health > ADHD Though not a first-line treatment, bupropion may support adults with ADHD by improving focus, reducing impulsivity, and addressing comorbid depressive symptoms. - Diet > Appetite Suppressants Designed to help reduce food cravings and control eating behaviors by modulating both appetite regulation and dopamine-driven reward pathways. A useful aid in clinical obesity and lifestyle-associated overeating.
Naltrexone acts as an opioid receptor antagonist, disrupting the reward feedback loop associated with compulsive eating. Bupropion, a norepinephrine-dopamine reuptake inhibitor (NDRI), improves mood and decreases appetite. Together, they create a dual-action approach that curbs hunger while addressing underlying behavioral and emotional patterns linked to obesity, smoking, or depression.
Each extended-release tablet contains naltrexone 8mg and bupropion 90mg. - Week 1: 1 tablet in the morning - Week 2: 1 tablet twice daily (morning and evening) - Week 3: 2 tablets in the morning, 1 in the evening - Week 4 and beyond: 2 tablets twice daily Maximum daily dose: 4 tablets/day (naltrexone 32mg + bupropion 360mg) If no ≥5% weight loss is achieved after 12 weeks at full dose, treatment should be reconsidered. Avoid combining with other weight loss agents. Cardiovascular safety over long-term use is not fully established.
Store below 25°C in a dry place, protected from sunlight and moisture. Keep out of reach of children and do not use after expiry date.
Common side effects include nausea, headache, insomnia, dry mouth, dizziness, and anxiety. Less frequent but serious side effects may include increased blood pressure, seizure risk, or suicidal thoughts. Seek medical attention if severe mood changes, chest pain, or hallucinations occur.
No reviews yet. Be the first to review this product!
No combo deals available at the moment.
